Patents by Inventor Henry H. Chan

Henry H. Chan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240034789
    Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to signal regulatory protein-? (SIRP?) and modulate the activity of SIRP?.
    Type: Application
    Filed: February 1, 2023
    Publication date: February 1, 2024
    Inventors: Mahan Abbasian, Henry H. Chan, Laure Escoubet, Gustavo Fenalti, Kandasamy Hariharan, Monica Wai Ling Leung, Konstantinos Mavrommatis, David P. Mikolon, Heather K. Raymon, Carlo Steven Santos, Jeonghoon Sun, Christina Valerie Trout
  • Publication number: 20230272076
    Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Application
    Filed: August 1, 2022
    Publication date: August 31, 2023
    Inventors: Brydon Bennett, Philip P. Chamberlain, Kandasamy Hariharan, Pilgrim Jackson, Marilyn Kehry, Roli Khattri, Monica Leung, Lisa Morrison, Jeonghoon Sun, Sanaa Torres, Henry H. Chan
  • Patent number: 11591390
    Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to signal regulatory protein-? (SIRP?) and modulate the activity of SIRP?.
    Type: Grant
    Filed: September 25, 2019
    Date of Patent: February 28, 2023
    Assignee: Celgene Corporation
    Inventors: Mahan Abbasian, Henry H. Chan, Laure Escoubet, Gustavo Fenalti, Kandasamy Hariharan, Monica Wai Ling Leung, Konstantinos Mavrommatis, David P. Mikolon, Heather K. Raymon, Carlo Steven Santos, Jeonghoon Sun, Christina Valerie Trout
  • Publication number: 20210069325
    Abstract: Provided herein are methods for managing, treating, or preventing immune disorders, such as autoimmune diseases, using proteins that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Application
    Filed: July 31, 2020
    Publication date: March 11, 2021
    Inventors: Henry H. Chan, Eun Mi Hur, Roli Khattri, Monica Leung, Garth E. Ringheim, Peter H. Schafer
  • Patent number: 10751414
    Abstract: Provided herein are methods for managing, treating, or preventing immune disorders, such as autoimmune diseases, using proteins that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: August 25, 2020
    Assignee: Celgene Corporation
    Inventors: Henry H. Chan, Eun Mi Hur, Roli Khattri, Monica Leung, Garth E. Ringheim, Peter H. Schafer
  • Publication number: 20200255525
    Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Application
    Filed: September 17, 2019
    Publication date: August 13, 2020
    Inventors: Brydon Bennett, Philip P. Chamberlain, Kandasamy Hariharan, Pilgrim Jackson, Marilyn Kehry, Roli Khattri, Monica Leung, Lisa Morrison, Jeonghoon Sun, Sanaa Torres, Henry H. Chan
  • Publication number: 20200102387
    Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to signal regulatory protein-? (SIRP?) and modulate the activity of SIRP?.
    Type: Application
    Filed: September 25, 2019
    Publication date: April 2, 2020
    Inventors: Mahan Abbasian, Henry H. Chan, Laure Escoubet, Gustavo Fenalti, Kandasamy Hariharan, Monica Wai Ling Leung, Konstantinos Mavrommatis, David P. Mikolon, Heather K. Raymon, Carlo Steven Santos, Jeonghoon Sun, Christina Valerie Trout
  • Patent number: 10428145
    Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Grant
    Filed: September 28, 2016
    Date of Patent: October 1, 2019
    Assignee: Celgene Corporation
    Inventors: Brydon Bennett, Philip Paul Chamberlain, Kandasamy Hariharan, Pilgrim Jackson, Marilyn Kehry, Roli Khattri, Monica Leung, Lisa Morrison, Jeonghoon Sun, Sanaa Torres, Henry H. Chan
  • Publication number: 20180092975
    Abstract: Provided herein are methods for managing, treating, or preventing immune disorders, such as autoimmune diseases, using proteins that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Application
    Filed: September 18, 2017
    Publication date: April 5, 2018
    Inventors: Henry H. CHAN, Eun Mi HUR, Roli KHATTRI, Monica LEUNG, Garth E. RINGHEIM, Peter H. SCHAFER
  • Publication number: 20170088618
    Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Application
    Filed: September 28, 2016
    Publication date: March 30, 2017
    Inventors: Brydon Bennett, Philip Paul Chamberlain, Kandasamy Hariharan, Pilgrim Jackson, Marilyn Kehry, Roli Khattri, Monica Leung, Lisa Morrison, Jeonghoon Sun, Sanaa Torres, Henry H. Chan
  • Patent number: 8311652
    Abstract: An optimization method based on statistical modeling relating NGL plant process variables. The modeling may rely on input data from process history and modeled data. The method identifies process scenarios when a compressor from an associated propane/propylene refrigeration system may be deactivated and still allow the NGL plant to achieve product specification.
    Type: Grant
    Filed: March 28, 2008
    Date of Patent: November 13, 2012
    Assignee: Saudi Arabian Oil Company
    Inventors: Othman A. Taha, Henry H. Chan
  • Publication number: 20090248174
    Abstract: An optimization method based on statistical modeling relating NGL plant process variables. The modeling may rely on input data from process history and modeled data. The method identifies process scenarios when a compressor from an associated propane/propylene refrigeration system may be deactivated and still allow the NGL plant to achieve product specification.
    Type: Application
    Filed: March 28, 2008
    Publication date: October 1, 2009
    Applicant: SAUDI ARABIAN OIL COMPANY
    Inventors: Othman A. Taha, Henry H. Chan